Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
This triple mechanism distinguishes it from dual-agonist peptides like tirzepatide (GLP-1/GIP) and single-agonist compounds like semaglutide (GLP-1 only), making it the most broadly acting incretin-class compound currently under clinical investigation
Third-Party Tested Peptides: The vendors peptides undergo thorough HPLC-MS testing by third-party laboratories
[1] [3] It has also received UK approval for weight management in adults with obesity or overweight with weight-related comorbidities, subject to specific NICE eligibility criteria
A professional must review your history to determine if a GLP-1 medication is appropriate for you
US$ 25.98
US$ 22.06
US$ 20.66
US$ 28.27
US$ 24.38
